logo

For the Inventor, By the Inventor

Jacou, France

Medincell S.a.

Calculating rank
USPTO Granted Patents = 11


Trademarks = 3

Forward Citations = 1

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Christophe Roberge (5 out of 7 patents)

silverMedal Eran Harary (4 out of 4 patents)

bronzeMedal Sylvestre Grizot (4 out of 4 patents)

4.  Jean-Manuel Cros (3 out of 5 patents)

5.  Anthony Rech (3 out of 5 patents)

6.  Adolfo López-Noriega (3 out of 5 patents)

7.  Juliette Serindoux (3 out of 5 patents)

8.  Anna Elgart Valitsky (3 out of 3 patents)

9.  Georges Gaudriault (2 out of 4 patents)

10.  Matthew Shive (2 out of 2 patents)

11.  Mark Hurtig (2 out of 2 patents)

12.  Feifei Ng (2 out of 2 patents)

13.  Marie-Emérentienne Cagnon (2 out of 2 patents)

14.  Fang Liu (2 out of 2 patents)

15.  Tjasa Vrlinic (2 out of 2 patents)


11 patents:

1. 12746197 - Long acting injectable formulation comprising risperidone and biodegradable polymers (2026-09-29),
2. 12560950 - Flow control device (2026-02-24),
3. 12558309 - Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue (2026-02-24),
4. 12485139 - Pharmaceutical composition (2025-12-02),
5. 12427165 - Pharmaceutical composition (2025-09-30),
6. 12383493 - Drug delivery formulations (2025-08-12),
7. 12329851 - Long acting injectable formulation comprising risperidone and biodegradable polymers (2025-06-17),
8. 12220418 - Olanzapine compositions and methods of use (2025-02-11),
9. 12128132 - Drug delivery formulations (2024-10-29),
10. 11865205 - Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue (2024-01-09),
11. 11801217 - Biodegradable block copolymer drug delivery composition (2023-10-31),
Company Overview
Medincell S.a. is a biopharmaceutical company based in Jacou, France, specializing in the development of innovative drug delivery systems. The company focuses on long-acting injectable formulations that enhance patient compliance and therapeutic outcomes. Medincell's proprietary technology platform enables the formulation of various therapeutic agents, targeting a range of medical conditions. With a commitment to advancing healthcare solutions, Medincell collaborates with partners to bring its products from concept to market, aiming to improve patient care globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

11 Patents

#1 in Jacou

#1,586 in France

#51,873 in the World

Jacou, FR
Jacou, France

Medincell S.a.

Forward Citations = 1

34 inventors:

goldMedal Christophe Roberge (5 out of 7 patents)

silverMedal Eran Harary (4 out of 4 patents)

bronzeMedal Sylvestre Grizot (4 out of 4 patents)

4.  Jean-Manuel Cros (3 out of 5 patents)

5.  Anthony Rech (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medincell S.a.. Retrieved from https://idiyas.com/company/medincell-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…